ColombiaTaevas Global acts as your authorized legal representative before INVIMA, enabling medical devices manufacturers to obtain market authorization, maintain regulatory standing, and operate compliantly in Colombia without establishing a local entity from day
Our legal representation service is built on six interconnected pillars that cover every dimension of regulatory compliance, market entry, and ongoing commercial operations in Colombia.
We serve as your official legal representative before INVIMA, Colombia's national food and drug surveillance institute, to manage all device registration filings. Our team prepares, submits, and tracks Registro Sanitario applications across all device risk classes. We ensure your technical dossiers meet Decree 4725 of 2005 and current INVIMA resolution requirements.
Our four-step engagement takes medical devices manufacturers from initial scoping through active INVIMA representation in a structured, transparent process designed to minimize delays and maximize regulatory certainty.
We begin with a structured intake call to understand your device portfolio, intended use, existing international registrations, and Colombia market objectives. A preliminary risk classification and registration pathway analysis is completed within 48 hours. You receive a clear scope of work and engagement proposal before any commitment is made.
During intake, our regulatory specialists review any existing CE marks, FDA clearances, or Health Canada licenses that may support an accelerated Colombian pathway. We identify which devices qualify for recognition of foreign approvals under INVIMA's equivalence provisions and flag any documentation gaps that must be resolved before filing. This assessment forms the foundation of your Colombia regulatory strategy.
Colombia is the third-largest medical devices market in Latin America, behind Brazil and Mexico, and the largest in the Andean Community. The country's 50 million population, expanding middle class, and government investment in universal health coverage under the SGSSS system drive consistent demand for imported diagnostic, surgical, and therapeutic devices. Over 85 percent of medical devices consumed in Colombia are imported, creating substantial opportunity for foreign manufacturers.
All medical devices sold in Colombia must hold a valid Registro Sanitario issued by INVIMA under the framework established by Decree 4725 of 2005 and subsequent resolutions. Devices are classified into four risk classes, with Class I representing the lowest risk and Class III the highest, each requiring progressively more extensive technical evidence. Foreign manufacturers must appoint a local legal representative as a mandatory condition of registration, making this the critical first compliance step for market entry.
A substantial share of medical device purchases in Colombia flows through public health institutions affiliated with the General Social Security Health System, including EPS insurers and IPS hospitals. Government tenders for devices frequently require valid INVIMA registration as a bid eligibility condition, meaning companies without a Registro Sanitario are locked out of a major demand channel. Taevas Global's legal representation service ensures clients are registration-ready before procurement cycles open.
Colombia's Ministry of Health has prioritized digital health infrastructure, creating growing demand for diagnostic imaging, in-vitro diagnostics, and connected health monitoring devices. INVIMA has issued specific guidance on software as a medical device and AI-enabled diagnostic tools, reflecting the regulator's effort to keep pace with technological innovation. Manufacturers of advanced diagnostic and digital health products face a nuanced regulatory environment that rewards early engagement with an experienced legal representative.
Every Legal Representation engagement with Taevas Global includes a defined set of regulatory, legal, and advisory deliverables designed to give medical devices manufacturers complete coverage from first filing through ongoing market maintenance.
A written analysis of the applicable INVIMA registration pathway for each device in your portfolio, including risk classification rationale and estimated timelines based on current INVIMA processing data.
Full preparation of the INVIMA submission dossier, including device descriptions, clinical evidence summaries, quality system documentation, and Spanish-language labeling review aligned with Decree 4725 requirements.
A structured gap analysis comparing your existing international regulatory documentation against INVIMA's specific requirements, with a prioritized remediation plan for any missing or non-compliant elements.
Preparation and execution of all legal representative appointment instruments required by INVIMA, including the notarized and apostilled power of attorney and manufacturer authorization letter.
End-to-end management of the INVIMA online submission process, with real-time tracking of application status and proactive follow-up on information requests or deficiency letters issued by the regulator.
Review of your existing or planned distribution agreements to ensure they are structurally consistent with the INVIMA registration holder and legal representative requirements, preventing channel conflicts that can jeopardize market access.
A Colombia-specific post-market surveillance framework covering adverse event reporting obligations, field safety corrective action procedures, and INVIMA notification requirements applicable to your registered devices.
Continuous legal representation before INVIMA throughout the ten-year Registro Sanitario term, including regulatory change monitoring, modification notifications, and proactive renewal planning to ensure uninterrupted market access.
Your device has regulatory approval in the US, EU, or another major market and you are ready to pursue Colombia as your next commercial territory. You need a local legal representative to satisfy INVIMA's mandatory requirement and a regulatory partner who can translate your existing documentation into a compliant Colombian submission. Without this step, you cannot legally market or sell your device in Colombia regardless of your international approvals.
Speak with a Taevas Global regulatory specialist today to assess your Colombia registration pathway, understand your legal representation requirements, and get a clear timeline and cost estimate for your INVIMA submission.